These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33420874)

  • 21. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
    Atkins BZ; Hashmi ZA; Ganapathi AM; Harrison JK; Hughes GC; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1247-52. PubMed ID: 23870154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous closure of the aortic valve as a bridge to heart transplantation to treat severe aortic insufficiency after ventricular assist device.
    Sauer AJ; Davidson CJ; McGee EC
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):E103-6. PubMed ID: 24975484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological analysis of the aortic valve after long-term left ventricular assist device support.
    Hata H; Fujita T; Ishibashi-Ueda H; Nakatani T; Kobayashi J
    Eur J Cardiothorac Surg; 2014 Aug; 46(2):193-7. PubMed ID: 24335262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late de novo aortic regurgitation with the Jarvik 2000 Flowmaker® left ventricular assist device.
    Rossi M; Serraino GF; Jiritano F; Renzulli A
    Int J Artif Organs; 2012 Dec; 35(12):1080-2. PubMed ID: 23065895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device.
    Oishi H; Kondo T; Fujimoto K; Mutsuga M; Morimoto R; Hirano KI; Sawamura A; Kazama S; Kimura Y; Shibata N; Kato H; Arao Y; Kuwayama T; Yamaguchi S; Hiraiwa H; Okumura T; Usui A; Murohara T
    J Artif Organs; 2020 Dec; 23(4):378-382. PubMed ID: 32562105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of patient-specific computational models for optimization of aortic insufficiency after implantation of left ventricular assist device.
    Kasinpila P; Kong S; Fong R; Shad R; Kaiser AD; Marsden AL; Woo YJ; Hiesinger W
    J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1556-1563. PubMed ID: 32653292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.
    Schechter MA; Joseph JT; Krishnamoorthy A; Finet JE; Ganapathi AM; Lodge AJ; Milano CA; Patel CB
    J Heart Lung Transplant; 2014 Sep; 33(9):937-42. PubMed ID: 24997496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo aortic insufficiency during long-term support on a left ventricular assist device: a systematic review and meta-analysis.
    Deo SV; Sharma V; Cho YH; Shah IK; Park SJ
    ASAIO J; 2014; 60(2):183-8. PubMed ID: 24399060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of worsening of aortic insufficiency during HeartMate 3 LVAD support.
    Imamura T; Narang N; Kim G; Nitta D; Fujino T; Nguyen A; Grinstein J; Rodgers D; Ota T; Raikhelkar J; Jeevanandam V; Sayer G; Uriel N
    Artif Organs; 2021 Mar; 45(3):297-302. PubMed ID: 33098153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support.
    Jimenez Contreras F; Mendiola Pla M; Schroder J; Bryner B; Agarwal R; Russell SD; Mirza J; Daneshmand MA; Milano C
    Eur J Cardiothorac Surg; 2022 May; 61(5):1188-1196. PubMed ID: 35167677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed Speed Reduction Enables Aortic Valve Opening and Increased Pulsatility in the LVAD-Assisted Heart.
    Tolpen S; Janmaat J; Reider C; Kallel F; Farrar D; May-Newman K
    ASAIO J; 2015; 61(5):540-7. PubMed ID: 25961849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment With Impella Increases the Risk of De Novo Aortic Insufficiency Post Left Ventricular Assist Device Implant.
    Rao SD; Johnson B; Olia SE; Wald J; Medina V; Rame JE; Mazurek JA; Goldberg LR; Atluri P; Bermudez C; Acker M; Birati EY
    J Card Fail; 2020 Oct; 26(10):870-875. PubMed ID: 32681883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of turbulent blood flow in the aortic root on de novo aortic insufficiency during continuous-flow left ventricular-assist device support.
    Yoshida S; Toda K; Miyagawa S; Yoshikawa Y; Hata H; Yoshioka D; Kainuma S; Kawamura T; Kawamura A; Nakatani S; Sawa Y
    Artif Organs; 2020 Aug; 44(8):883-891. PubMed ID: 32080864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant aortic valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis.
    Robertson JO; Naftel DC; Myers SL; Prasad S; Mertz GD; Itoh A; Pagani FD; Kirklin JK; Silvestry SC
    J Heart Lung Transplant; 2015 Jun; 34(6):797-805. PubMed ID: 25511747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous-Flow Left Ventricular Assist Devices and the Aortic Valve: Interactions, Issues, and Surgical Therapy.
    Goodwin ML; Bobba CM; Mokadam NA; Whitson BA; Essandoh M; Hasan A; Ganapathi AM
    Curr Heart Fail Rep; 2020 Aug; 17(4):97-105. PubMed ID: 32488504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous aortic valve replacement in left ventricular assist device recipients: single-center experience.
    Dranishnikov N; Stepanenko A; Potapov EV; Dandel M; Siniawski H; Mladenow A; Hübler M; Grauhan O; Weng Y; Krabatsch T; Hetzer R; Kukucka M
    Int J Artif Organs; 2012 Jul; 35(7):489-94. PubMed ID: 22661109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
    Parikh KS; Mehrotra AK; Russo MJ; Lang RM; Anderson A; Jeevanandam V; Freed BH; Paul JD; Karol J; Nathan S; Shah AP
    JACC Cardiovasc Interv; 2013 Jan; 6(1):84-9. PubMed ID: 23347865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of aortic insufficiency in left ventricular assist device-supported patients.
    Cowger J; Pagani FD; Haft JW; Romano MA; Aaronson KD; Kolias TJ
    Circ Heart Fail; 2010 Nov; 3(6):668-74. PubMed ID: 20739615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.